Free Trial

NKGen Biotech (NKGN) SEC Filings & 10K Form

NKGen Biotech logo
$0.57 +0.12 (+27.12%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$0.50 -0.07 (-12.20%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NKGen Biotech SEC Filings

DateFilerForm TypeView
02/14/2025
9:34 AM
METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SCHEDULE 13G/A
02/03/2025
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form DEF 14A
01/08/2025
4:29 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:54 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
6:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
6:20 PM
Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:01 PM
Graf Acquisition Partners IV LLC (Reporting)
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
4:23 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:55 PM
Graf James A (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Song Paul Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM
Klowden Michael (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
8:56 PM
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Scott Kathleen D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:10 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
4:22 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:01 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
5:06 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
5:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
4:25 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:00 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
5:09 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
3:30 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
4:16 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/11/2024
4:26 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
6:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
7:00 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
5:45 PM
CFIC-2015 NV Family Investments, LLC (Reporting)
Cherng Andrew Jin-Chan (Reporting)
CHERNG PEGGY (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/22/2024
4:22 PM
CFIC-2015 NV Family Investments, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G
08/22/2024
3:42 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
7:31 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form ARS
07/22/2024
4:19 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form DEF 14A
07/18/2024
4:52 PM
Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
4:53 PM
Gottardis Marco (Reporting)
NKGen Biotech, Inc. (Issuer)
NKGen Biotech (Issuer)
NKGen Biotech, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
3:25 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
7:15 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:58 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form PRER14A
07/12/2024
6:19 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
4:21 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 424B3
07/08/2024
11:15 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form EFFECT
06/27/2024
3:34 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

06/21/2024
3:14 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:54 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form S-1/A
05/13/2024
7:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
1:42 PM
METEORA CAPITAL, LLC (Filed by)
NKGen Biotech, Inc. (Subject)
NKGen Biotech (Subject)
NKGen Biotech, Inc. (Subject)
Form SC 13G/A
04/29/2024
4:20 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-K/A
04/16/2024
2:07 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/11/2024
7:05 AM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2024
3:55 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
4:02 PM
NKGen Biotech, Inc. (Filer)
NKGen Biotech (Filer)
NKGen Biotech, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:NKGN) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners